標(biāo)題: Titlebook: Chronic Lymphocytic Leukemia; Molecular Genetics, Guy B. Faguet Book 2004 Springer Science+Business Media New York 2004 Staging.antibody.c [打印本頁(yè)] 作者: 重婚 時(shí)間: 2025-3-21 19:30
書目名稱Chronic Lymphocytic Leukemia影響因子(影響力)
作者: 鳴叫 時(shí)間: 2025-3-21 23:43 作者: 不可知論 時(shí)間: 2025-3-22 03:06 作者: metropolitan 時(shí)間: 2025-3-22 05:06 作者: flaunt 時(shí)間: 2025-3-22 08:55 作者: Autobiography 時(shí)間: 2025-3-22 15:00
Genetics of B-Cell Chronic Lymphocytic Leukemiaon and antibody therapies are currently being investigated. The prognosis is influenced by the degree of dissemination of the disease at the time of diagnosis. This is reflected in the prognostic importance of the clinical staging systems defined by Rai and Binet ..Both systems differentiate among e作者: Autobiography 時(shí)間: 2025-3-22 18:35 作者: Myelin 時(shí)間: 2025-3-22 22:42
Immunophenotypic Differential Diagnosis and Cell Cycle Analysisc and molecular information provided further tools in refining CLL as a distinct entity. For example, in 1989, the entity of mantle cell lymphoma (MCL) was separated from CLL/SLL as a distinct disease .. Thus, more than 30 years after its first phenotypic description, the definition of CLL is still 作者: cloture 時(shí)間: 2025-3-23 05:24 作者: conflate 時(shí)間: 2025-3-23 06:58
Autologous and Allogeneic Transplantations for Chronic Lymphocytic Leukemiallogeneic settings, the graft-vs-leukemia (GVL) activity should be responsible for very substantial disease control . and seems to cure a subset of poor-risk patients but at the price of an excessively high treatment-related mortality (TRM) .. The recent development of a nonmyeloablative conditionin作者: 離開就切除 時(shí)間: 2025-3-23 13:04
Intravenous Regional Sympathetic Blocksiate clinical behavior, with slowly increasing leukocytosis and progressive lymphadenopathy and organomegaly, and patients will require treatment at some point. (More details on the epidemiology and clinical presentation of CLL are described in other chapters of this textbook).作者: 手榴彈 時(shí)間: 2025-3-23 13:53
Chemotherapy of Chronic Lymphocytic Leukemiaiate clinical behavior, with slowly increasing leukocytosis and progressive lymphadenopathy and organomegaly, and patients will require treatment at some point. (More details on the epidemiology and clinical presentation of CLL are described in other chapters of this textbook).作者: Graves’-disease 時(shí)間: 2025-3-23 19:25 作者: 小隔間 時(shí)間: 2025-3-24 01:21
Book 2004ication to the best management of CLL. The authors focus on diagnosis, prognosis, multifaceted treatment options, and complications. Among the diverse treatments considered are chemotherapy, autologous and allogenic transplantations, monoclonal antibody therapy, immunotoxin therapy, gene therapy, an作者: 嚴(yán)重傷害 時(shí)間: 2025-3-24 03:25 作者: Flinch 時(shí)間: 2025-3-24 08:10 作者: galley 時(shí)間: 2025-3-24 11:18 作者: 容易做 時(shí)間: 2025-3-24 15:50 作者: demote 時(shí)間: 2025-3-24 20:33
https://doi.org/10.1007/978-3-031-52854-5L) are usually considered; within the primary lymphomas, follicular lymphoma (FL), mantle cell lymphoma (MCL), marginal zone splenic lymphoma (MZSL), lymphoplasmacytic lymphoma (LPL), and the large B-cell lymphomas (LCLs) exhibit PB involvement more frequently ..作者: 來這真柔軟 時(shí)間: 2025-3-25 01:00
Vom Kreislaufapparat ausgehende Reflexe,ge proportion of patients are now being diagnosed while asymptomatic and at a much younger age than previously. This results in longer overall survival, but it also poses special problems in respect to clinical management .,..作者: limber 時(shí)間: 2025-3-25 06:37
The Natural History of CLLinical entity, 1845–1924; (2) initial clinical investigations, 1924–1973; and (3) the modern era, 1973–2002. We too have found this division informative and have grouped the events into those three periods.作者: GAVEL 時(shí)間: 2025-3-25 09:29 作者: 逢迎白雪 時(shí)間: 2025-3-25 15:24 作者: 切掉 時(shí)間: 2025-3-25 19:41
Prognostic Indicators of Chronic Lymphocytic Leukemiage proportion of patients are now being diagnosed while asymptomatic and at a much younger age than previously. This results in longer overall survival, but it also poses special problems in respect to clinical management .,..作者: climax 時(shí)間: 2025-3-25 21:02
Reflektierender Faraday-Effekt-Stromsensornvironment, including tissue-specific stroma, cytokine levels, vascular supply, and the host immune system, contribute to the augmentation and/or stabilize CLL B-cell apoptotic resistance. Thus, we have been interested in the study of both the qualitative and quantitative nature of the immune system in B-CLL.作者: Palpable 時(shí)間: 2025-3-26 03:30
Stufe 4: Formulierung einer Zielsetzungrent stages and thus help in predicting the course of the disease and survival outlook with a reasonable certainty. Moreover, stratification of the patients according to stage enables investigators to design and conduct clinical trials evaluating the efficacy of new therapeutic strategies.作者: mercenary 時(shí)間: 2025-3-26 06:24
Pathogenesis of Impaired Cellular Immune Function in CLLnvironment, including tissue-specific stroma, cytokine levels, vascular supply, and the host immune system, contribute to the augmentation and/or stabilize CLL B-cell apoptotic resistance. Thus, we have been interested in the study of both the qualitative and quantitative nature of the immune system in B-CLL.作者: Hectic 時(shí)間: 2025-3-26 10:43
Staging of Chronic Lymphocytic Leukemiarent stages and thus help in predicting the course of the disease and survival outlook with a reasonable certainty. Moreover, stratification of the patients according to stage enables investigators to design and conduct clinical trials evaluating the efficacy of new therapeutic strategies.作者: 注入 時(shí)間: 2025-3-26 15:15
Guy B. FaguetIncludes supplementary material: 作者: crutch 時(shí)間: 2025-3-26 20:11 作者: SEED 時(shí)間: 2025-3-26 22:19
https://doi.org/10.1007/978-981-10-3431-2hese discoveries will shed new light on the etiology of diseases and the mechanisms that determine their clinical behavior. They will also help explain the diversity in disease progression and response to treatment and identify new therapeutic targets with the ultimate goal of cure.作者: STALL 時(shí)間: 2025-3-27 03:03
https://doi.org/10.1007/978-1-4613-0685-6 mature, slowly dividing, monoclonal B-lymphocytes .. Affected patients are always adults: the median age at diagnosis is 64 yr. BCLL cells are characterized by coexpression of the pan-B -cell markers CD5 and CD23, negativity for CD22 and FMC7 molecules, and low expression of the B-cell receptor surface Ig and Igassociated molecule CD79b ..作者: labyrinth 時(shí)間: 2025-3-27 08:07
Molecular Biology of Chronic Lymphocytic Leukemiahese discoveries will shed new light on the etiology of diseases and the mechanisms that determine their clinical behavior. They will also help explain the diversity in disease progression and response to treatment and identify new therapeutic targets with the ultimate goal of cure.作者: LIKEN 時(shí)間: 2025-3-27 09:54 作者: browbeat 時(shí)間: 2025-3-27 15:56
https://doi.org/10.1007/978-1-59259-412-2Staging; antibody; cell; chemotherapy; cytokine; cytokines; evolution; gene therapy; genes; genetics; leukemia作者: 令人心醉 時(shí)間: 2025-3-27 21:34
978-1-61737-355-8Springer Science+Business Media New York 2004作者: mettlesome 時(shí)間: 2025-3-27 22:44 作者: BRAND 時(shí)間: 2025-3-28 03:18 作者: 提升 時(shí)間: 2025-3-28 07:15 作者: aggressor 時(shí)間: 2025-3-28 12:56 作者: Communal 時(shí)間: 2025-3-28 15:02
Reflektierender Faraday-Effekt-Stromsensorsion of both CD19 and CD5 antigens (. Chapter 7). The clinical events characterizing the patients who eventually progress are most often linked to an accumulation of clonal CD5+ leukemic cells, particularly in the bone marrow, lymph nodes, and spleen. Although the hallmark of the leukemic CLL B-cell作者: 匍匐前進(jìn) 時(shí)間: 2025-3-28 20:47
https://doi.org/10.1007/978-3-658-09445-4are still largely unknown, but there is growing evidence of the important role played by cytokine networks and soluble mediators in the leukemic process. Leukemic CLL cells represent the most prominent population in CLL, but not the only one. Accessory non-neoplastic hematopoietic cells circulate in作者: antenna 時(shí)間: 2025-3-29 01:43
https://doi.org/10.1007/978-3-658-35376-6clinically described over 175 years ago, continues to evolve as an entity. As a result, the list of differential diagnoses for CLL also continues to evolve. Before the advent of immunophenotyping, the diagnosis of CLL included an assortment of diseases from circulating follicular lymphoma to large g作者: 喊叫 時(shí)間: 2025-3-29 04:33 作者: 驚奇 時(shí)間: 2025-3-29 10:05 作者: NOVA 時(shí)間: 2025-3-29 14:51 作者: Highbrow 時(shí)間: 2025-3-29 17:56
Vom Kreislaufapparat ausgehende Reflexe, (Fig. 1), in individual patients the prognosis is extremely variable, ranging from a very short to a normal life span. Thus, some CLL patients will have an excellent prognosis and will never require treatment, whereas in others the prognosis is poor and prompt treatment is required. Moreover, a lar作者: 不可侵犯 時(shí)間: 2025-3-29 23:48 作者: 初學(xué)者 時(shí)間: 2025-3-30 03:08 作者: BARGE 時(shí)間: 2025-3-30 06:40
Intravenous Regional Sympathetic Blocksias in those regions. Patients with CLL are often asymptomatic at presentation, and the disease is discovered on routine examination. The course of the disease is heterogeneous: a subset of patients will have indolent disease, may never require therapy, and may eventually die of unrelated causes; an作者: Between 時(shí)間: 2025-3-30 10:29
